Company intelligence / Profile preview

Eximia Research

Dover, Delaware, United Stateseximiaresearch.com ↗

Ownership: Private
Development stage: Other

Overview

Eximia Research is an active, nationwide leader in the U.S. for conducting clinical research across diverse therapeutic indications. The company specializes in providing access to underrepresented patient populations and has expanded its reach through acquisitions such as Integrated Clinical Trial Services (ICTS) in Iowa. It offers Phase I-IV study execution for pharmaceutical, biotech, and medical device companies.

Therapeutic areas: OtherDermatologyMetabolic DisordersNeurology
Industry: Contract Research Organization

Beyond the preview

Go deeper on Eximia Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eximia Research.

Explore the full profile